This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Ryosuke Taga: Innovator in Heterocyclic Compounds
Introduction
Ryosuke Taga is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel heterocyclic compounds. His work focuses on compounds that have potential therapeutic applications, especially in promoting platelet production.
Latest Patents
Ryosuke Taga holds a patent for a heterocyclic compound that exhibits aryl hydrocarbon receptor antagonist activity. This compound is represented by a specific general formula and is useful for enhancing platelet production. The patent highlights the innovative nature of his work and its potential impact on medical treatments.
Career Highlights
Ryosuke Taga is associated with Otsuka Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His career is marked by a commitment to innovation in pharmaceutical chemistry, contributing to the company's mission of improving health outcomes.
Collaborations
Throughout his career, Ryosuke has collaborated with esteemed colleagues such as Kazuhiro Ohdachi and Yusuke Fujimori. These collaborations have fostered a productive environment for research and innovation, leading to advancements in their respective fields.
Conclusion
Ryosuke Taga is a distinguished inventor whose work in heterocyclic compounds showcases his dedication to scientific advancement. His contributions have the potential to influence therapeutic practices significantly.